FDA Approved: IBANDRONATE SODIUM — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved the original generic application for ibandronate sodium by Bionpharma Inc., enabling a generic version of the osteoporosis treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)